top
Search terms
Results 1921 - 1924 of 1924 - ordered by :
Pages: 1 ... 187 188 189 190 191 192 193
Escardio

Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented at ESC Congress 2014 today by Dr Maciej ...

Date : 31/08/2014
Escardio

Professor John Eikelboom, principal investigator, of the Population Health Research Institute, McMaster University, Hamilton, Canada, said: “In patients with stable coronary artery disease or ...

Date : 26/08/2018
Escardio

Drug cuts cardiovascular disease and lung cancer risk by reducing inflammation (CANTOS) The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...

Date : 27/08/2017
Escardio

Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, ...

Date : 21/08/2014